Leishmania major stress-inducible protein 1 (LmSTI1)

Leishmania major stress-inducible protein 1 (LmSTI1) is a highly conserved co-chaperone that plays a critical role in the parasite's adaptation to environmental stress, particularly the temperature shift encountered during transmission from the sand fly vector to the mammalian host [1, 15]. It functions by organizing the Hsp70/Hsp90 chaperone complex, facilitating the transfer of client proteins and modulating their folding and activity [1, 15]. LmSTI1 is a prominent target in the development of recombinant and DNA vaccines against leishmaniasis, most notably as a core component of the polyprotein vaccine Leish-111f (also known as LEISH-F1) [5, 16]. Immunization with LmSTI1 has been shown to elicit a robust Th1-type immune response, which is essential for the activation of macrophages and subsequent destruction of intracellular parasites [4, 5, 12]. While primarily pursued as a vaccine antigen, its essential role in parasite proteostasis also makes it a potential target for small-molecule inhibitors designed to disrupt the chaperone machinery [17, 29].

Other names

LmSTI1Stress-inducible protein 1Stress-induced phosphoprotein 1STI1Hsp70/Hsp90-organizing proteinHopp60

Induction of a Th1-type immune response characterized by high levels of interferon-gamma (IFN-gamma) and interleukin-12 (IL-12), and low levels of interleukin-4 (IL-4), leading to macrophage activation and parasite clearance [4, 5, 12].